Page last updated: 2024-10-29

imipramine and Immune System Diseases

imipramine has been researched along with Immune System Diseases in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
STAEHELIN, B1
WORTMANN, F1

Other Studies

2 other studies available for imipramine and Immune System Diseases

ArticleYear
[Reports on the effectiveness of tofranil (Geigy) with special reference to allergic problems].
    Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie, 1959, Volume: 84

    Topics: Hypersensitivity; Imipramine; Immune System Diseases; Tranquilizing Agents

1959
[Experiences with the new combination preparation Nisorex (Geigy)].
    Therapeutische Umschau. Revue therapeutique, 1962, Volume: 19

    Topics: Dermatology; Histamine H1 Antagonists; Hypersensitivity; Imipramine; Immune System Diseases

1962